By coating tiny gel beads with lung-derived stem cells and then allowing them to self-assemble into the shapes of the air sacs found in human lungs, researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have succeeded in creating three-dimensional lung “organoids.” The laboratory-grown lung-like tissue can be used to study diseases including idiopathic pulmonary fibrosis, which has traditionally been difficult to study using conventional methods.
“While we haven’t built a fully functional lung, we’ve been able to take lung cells and place them in the correct geometrical spacing and pattern to mimic a human lung,” said Dr. Brigitte Gomperts, an associate professor of pediatric hematology/oncology and the study’s lead author.
Idiopathic pulmonary fibrosis is a chronic lung disease characterized by scarring of the lungs. The scarring makes the lungs thick and stiff, which over time results in progressively worsening shortness of breath and lack of oxygen to the brain and vital organs. After diagnosis, most people with the disease live about three to five years. Though researchers do not know what causes idiopathic pulmonary fibrosis in all cases, for a small percentage of people it runs in their families. Additionally, cigarette smoking and exposure to certain types of dust can increase the risk of developing the disease.
To study the effect of genetic mutations or drugs on lung cells, researchers have previously relied on two-dimensional cultures of the cells. But when they take cells from people with idiopathic pulmonary fibrosis and grow them on these flat cultures, the cells appear healthy. “Scientists have really not been able to model lung scarring in a dish,” said Gomperts, who is a member of the UCLA Broad Stem Cell Research Center. The inability to model idiopathic pulmonary fibrosis in the laboratory makes it difficult to study the biology of the disease and design possible treatments.
Gomperts and her colleagues started with stem cells created using cells from adult lungs. They used those cells to coat sticky hydrogel beads, and then they partitioned these beads into small wells, each only 7 millimeters across. Inside each well, the lung cells grew around the beads, which linked them and formed an evenly distributed three-dimensional pattern. To show that these tiny organoids mimicked the structure of actual lungs, the researchers compared the lab-grown tissues with real sections of human lung.
“The technique is very simple,” said Dan Wilkinson, a graduate student in the department of materials science and engineering and the paper’s first author. “We can make thousands of reproducible pieces of tissue that resemble lung and contain patient-specific cells.”
Moreover, when Wilkinson and Gomperts added certain molecular factors to the 3-D cultures, the lungs developed scars similar to those seen in the lungs of people who have idiopathic pulmonary fibrosis, something that could not be accomplished using two-dimensional cultures of these cells.
Using the new lung organoids, researchers will be able to study the biological underpinnings of lung diseases including idiopathic pulmonary fibrosis, and also test possible treatments for the diseases. To study an individual’s disease, or what drugs might work best in their case, clinicians could collect cells from the person, turn them into stem cells, coax those stem cells to differentiate into lung cells, then use those cells in 3-D cultures. Because it’s so easy to create many tiny organoids at once, researchers could screen the effect of many drugs. “This is the basis for precision medicine and personalized treatments,” Gomperts said.
The Latest on: Precision medicine
via Google News
The Latest on: Precision medicine
- Realizing precision medicine through pathogen genome sequencingon October 14, 2021 at 5:55 pm
Those familiar with the medical industry have undoubtedly heard the term "precision medicine" with great frequency. As a matter of fact, the development of genome sequencing technology in recent years ...
- Improving Precision Medicine Accessibility Among Admixed Populationson October 14, 2021 at 10:00 am
UC San Diego will open a new research center to study genomic and socioeconomic factors impacting health in admixed individuals, advancing precision medicine.
- Chasing Cancer: Precision Medicine with Eric Lefkofsky & Siddhartha Mukherjee, MDon October 14, 2021 at 8:51 am
New cancer treatments may be on the horizon thanks to the mRNA vaccines widely used to combat COVID-19. These new breakthroughs, coupled with advances in surgical techniques and targeted, ...
- New Alzheimer’s Treatment Advances Precision Medicineon October 13, 2021 at 10:00 am
Researchers found that a commonalty used oral diuretic pill is a potential treatment method for Alzheimer’s disease, improving precision medicine.
- Precision Medicine Gains Popularity In The Respiratory Diseases Drugs Marketon October 13, 2021 at 7:47 am
Respiratory Diseases Drugs Global Market Report 2021 - COVID-19 Impact And Recovery The Business Research Company's Respiratory Diseases ...
- Precision Medicine Market Future Scope, Demands and Projected Industry Growths to 2027on October 12, 2021 at 7:14 am
Market Study Report has released a new research study on Precision Medicine market Analysis 2021-2027 inclusive ...
- Precision medicine data dive shows water pill may be viable to test as Alzheimer’s treatmenton October 12, 2021 at 5:00 am
A commonly available, FDA-approved oral diuretic pill may be a potential candidate for an Alzheimer’s disease treatment for those who are at genetic risk, according to findings published in Nature ...
- Precision medicine data dive shows diuretic pill may be viable to test as Alzheimer's treatmenton October 11, 2021 at 6:52 pm
A commonly available, FDA-approved oral diuretic pill may be a potential candidate for an Alzheimer's disease treatment for those who are at genetic risk, according to new findings.
- Study Probes Role of Epigenetics in Precision Medicine for Lung Canceron October 11, 2021 at 1:45 pm
A new report could point the way toward improved precision therapy for patients with epidermal growth factor receptor (EGFR)-driven lung cancers. The study, published in the journal Advanced Science, ...
via Bing News